Bioiatriki Group unveils new corporate identity and MRI facility in Cyprus

On October 29, 2026, the Bioiatriki Group held a special event at its Multipurpose Diagnostic Center in Nicosia to inaugurate a new MRI department and announce a refreshed, unified corporate identity. The ceremony was attended by the government spokesperson representing the President of the Republic, the Archbishop of Cyprus, political representatives, and patient advocacy groups.

The Bioiatriki Group has operated in the Greek market for 45 years and has been active in Cyprus since 2017. Its expansion in the Cypriot market has been characterized by the strategic acquisition of Giannouka Labs, Alfa Evresis, and Pavlidis Labs. The company has developed an extensive network of laboratories and diagnostic centers across the country.

The new corporate identity will be implemented across all clinical laboratories and diagnostic centers within the Group. According to the company, this rebranding reflects a focus on evolution, innovation, and a long-term commitment to healthcare. The investment in the new MRI facility is presented as part of a broader commitment to enhancing diagnostic services in Cyprus.